Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 148

1.

Chromosome 1p and 11q deletions and outcome in neuroblastoma.

Attiyeh EF, London WB, Mossé YP, Wang Q, Winter C, Khazi D, McGrady PW, Seeger RC, Look AT, Shimada H, Brodeur GM, Cohn SL, Matthay KK, Maris JM; Children's Oncology Group.

N Engl J Med. 2005 Nov 24;353(21):2243-53.

2.

FISH analyses for alterations in chromosomes 1, 2, 3, and 11 define high-risk groups in neuroblastoma.

Spitz R, Hero B, Ernestus K, Berthold F.

Med Pediatr Oncol. 2003 Jul;41(1):30-5.

PMID:
12764740
3.

Comprehensive analysis of chromosome 1p deletions in neuroblastoma.

Maris JM, Guo C, Blake D, White PS, Hogarty MD, Thompson PM, Rajalingam V, Gerbing R, Stram DO, Matthay KK, Seeger RC, Brodeur GM.

Med Pediatr Oncol. 2001 Jan;36(1):32-6.

PMID:
11464900
4.

Quantitative real-time PCR for quick simultaneous determination of therapy-stratifying markers MYCN amplification, deletion 1p and 11q.

Boensch M, Oberthuer A, Fischer M, Skowron M, Oestreich J, Berthold F, Spitz R.

Diagn Mol Pathol. 2005 Sep;14(3):177-82.

PMID:
16106200
5.

Loss of heterozygosity at 1p36 independently predicts for disease progression but not decreased overall survival probability in neuroblastoma patients: a Children's Cancer Group study.

Maris JM, Weiss MJ, Guo C, Gerbing RB, Stram DO, White PS, Hogarty MD, Sulman EP, Thompson PM, Lukens JN, Matthay KK, Seeger RC, Brodeur GM.

J Clin Oncol. 2000 May;18(9):1888-99.

PMID:
10784629
6.

Allelic deletion at chromosome bands 11q14-23 is common in neuroblastoma.

Maris JM, Guo C, White PS, Hogarty MD, Thompson PM, Stram DO, Gerbing R, Matthay KK, Seeger RC, Brodeur GM.

Med Pediatr Oncol. 2001 Jan;36(1):24-7.

PMID:
11464895
7.

Survival analysis of clinical, pathologic, and genetic features in neuroblastoma presenting as locoregional disease.

Mora J, Cheung NK, Chen L, Qin J, Gerald W.

Cancer. 2001 Jan 15;91(2):435-42.

PMID:
11180092
8.

No evidence for the presence of an imprinted neuroblastoma suppressor gene within chromosome sub-band 1p36.3.

Hogarty MD, Winter CL, Liu X, Guo C, White PS, Look AT, Brodeur GM, Maris JM.

Cancer Res. 2002 Nov 15;62(22):6481-4.

9.

Allelic deletion at 11q23 is common in MYCN single copy neuroblastomas.

Guo C, White PS, Weiss MJ, Hogarty MD, Thompson PM, Stram DO, Gerbing R, Matthay KK, Seeger RC, Brodeur GM, Maris JM.

Oncogene. 1999 Sep 2;18(35):4948-57.

10.

Fluorescence in situ hybridization analyses of chromosome band 1p36 in neuroblastoma detect two classes of alterations.

Spitz R, Hero B, Westermann F, Ernestus K, Schwab M, Berthold F.

Genes Chromosomes Cancer. 2002 Jul;34(3):299-305.

PMID:
12007190
11.

High-resolution array copy number analyses for detection of deletion, gain, amplification and copy-neutral LOH in primary neuroblastoma tumors: four cases of homozygous deletions of the CDKN2A gene.

Carén H, Erichsen J, Olsson L, Enerbäck C, Sjöberg RM, Abrahamsson J, Kogner P, Martinsson T.

BMC Genomics. 2008 Jul 29;9:353. doi: 10.1186/1471-2164-9-353.

12.

New definition of low-risk neuroblastoma using stage, age, and 1p and MYCN status.

Simon T, Spitz R, Faldum A, Hero B, Berthold F.

J Pediatr Hematol Oncol. 2004 Dec;26(12):791-6.

PMID:
15591897
13.

Detection of MYCN amplification and chromosome 1p36 loss in neuroblastoma by cDNA microarray comparative genomic hybridization.

Scaruffi P, Parodi S, Mazzocco K, Defferrari R, Fontana V, Bonassi S, Tonini GP.

Mol Diagn. 2004;8(2):93-100.

PMID:
15527323
14.

Deletion of 11q23 is a frequent event in the evolution of MYCN single-copy high-risk neuroblastomas.

Guo C, White PS, Hogarty MD, Brodeur GM, Gerbing R, Stram DO, Maris JM.

Med Pediatr Oncol. 2000 Dec;35(6):544-6.

PMID:
11107113
15.

Correlation of modified Shimada classification with MYCN and 1p36 status detected by fluorescence in situ hybridization in neuroblastoma.

Altungoz O, Aygun N, Tumer S, Ozer E, Olgun N, Sakizli M.

Cancer Genet Cytogenet. 2007 Jan 15;172(2):113-9.

PMID:
17213019
17.

Loss of heterozygosity for chromosome 14q in neuroblastoma.

Thompson PM, Seifried BA, Kyemba SK, Jensen SJ, Guo C, Maris JM, Brodeur GM, Stram DO, Seeger RC, Gerbing R, Matthay KK, Matise TC, White PS.

Med Pediatr Oncol. 2001 Jan;36(1):28-31.

PMID:
11464899
18.

Biological characteristics of neuroblastoma with partial deletion in the short arm of chromosome 1.

Hiyama E, Hiyama K, Ohtsu K, Yamaoka H, Fukuba I, Matsuura Y, Yokoyama T.

Med Pediatr Oncol. 2001 Jan;36(1):67-74.

PMID:
11464909
19.

Constitutional 11q14-q22 chromosome deletion syndrome in a child with neuroblastoma MYCN single copy.

Passariello A, De Brasi D, Defferrari R, Genesio R, Tufano M, Mazzocco K, Capasso M, Migliorati R, Martinsson T, Siani P, Nitsch L, Tonini GP.

Eur J Med Genet. 2013 Nov;56(11):626-34. doi: 10.1016/j.ejmg.2013.08.005. Epub 2013 Sep 13.

PMID:
24035971
20.

Risk estimation in localized unresectable single copy MYCN neuroblastoma by the status of chromosomes 1p and 11q.

Simon T, Spitz R, Hero B, Berthold F, Faldum A.

Cancer Lett. 2006 Jun 18;237(2):215-22. Epub 2005 Jul 12.

PMID:
16019135

Supplemental Content

Support Center